Related references
Note: Only part of the references are listed.Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Benjamin J. Moss et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2022)
The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time
Wiwin Is Effendi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
Qianru Mei et al.
FRONTIERS IN PHARMACOLOGY (2022)
Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
Kazutaka Takehara et al.
CELLS (2022)
Sildenafil for idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Tyler Pitre et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2022)
Impact of timing of nintedanib initiation among patients newly diagnosed with idiopathic pulmonary fibrosis
David Singer et al.
JOURNAL OF MEDICAL ECONOMICS (2022)
New developments in the biology of fibroblast growth factors
David M. Ornitz et al.
WIRES MECHANISMS OF DISEASE (2022)
Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis A Population-Based Cohort Study
Tanja Tran et al.
CHEST (2021)
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
Thi Hang Giang Phan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Metabolic requirements of pulmonary fibrosis: role of fibroblast metabolism
Robert B. Hamanaka et al.
FEBS JOURNAL (2021)
TGF-β-induced fibrosis: A review on the underlying mechanism and potential therapeutic strategies
Chun Hao Ong et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study
Eung Gu Lee et al.
PLOS ONE (2021)
Therapeutic Targeting of IL-11 for Chronic Lung Disease
Rosa K. Kortekaas et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Efficacy and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis patients: a systematic review and meta-analysis of randomised controlled trials
Wenjuan Wu et al.
BMJ OPEN (2021)
Antifibrotic therapies reduce mortality and hospitalization among Medicare beneficiaries with idiopathic pulmonary fibrosis
Joshua Mooney et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2021)
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial
Fernando J. Martinez et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Lung gene expression and single cell analyses reveal two subsets of idiopathic pulmonary fibrosis (IPF) patients associated with different pathogenic mechanisms
Jozsef Karman et al.
PLOS ONE (2021)
The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis
Dan J. K. Yombo et al.
FRONTIERS IN IMMUNOLOGY (2021)
Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis
Elisa Baratella et al.
DIAGNOSTICS (2021)
FGF/FGFR signaling: From lung development to respiratory diseases
Lehe Yang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2021)
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Paula Montero et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Pathophysiological Roles of Stress-Activated Protein Kinases in Pulmonary Fibrosis
Yoshitoshi Kasuya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
New insights into the Hippo/YAP pathway in idiopathic pulmonary fibrosis
Mingyao Sun et al.
PHARMACOLOGICAL RESEARCH (2021)
Protective function of interleukin-22 in pulmonary fibrosis
Peiyu Gu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Azithromycin for the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis A Randomized Controlled Crossover Trial
Sabina A. Guler et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)
Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study
Pavo Marijic et al.
RESPIRATORY RESEARCH (2021)
VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
Hideki Amano et al.
INFLAMMATION AND REGENERATION (2021)
IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages
Li-Zong Rao et al.
CELL DEATH AND DIFFERENTIATION (2021)
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
Richard J. Allen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Notch signaling in the mammalian respiratory system, specifically the trachea and lungs, in development, homeostasis, regeneration, and disease
Hirofumi Kiyokawa et al.
DEVELOPMENT GROWTH & DIFFERENTIATION (2020)
Progressive Pulmonary Fibrosis Is Caused by Elevated Mechanical Tension on Alveolar Stem Cells
Huijuan Wu et al.
CELL (2020)
Inhibition of the ERK1/2-ubiquitous calpains pathway attenuates experimental pulmonary fibrosis in vivo and in vitro
Menglin Zou et al.
EXPERIMENTAL CELL RESEARCH (2020)
TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1
Jie Su et al.
NATURE (2020)
Targeting GPCR Signaling for Idiopathic Pulmonary Fibrosis Therapies
Andrew J. Haak et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation
Aja Aravamudhan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
Luca Richeldi et al.
BMC PULMONARY MEDICINE (2020)
IL-25/IL-33/TSLP contributes to idiopathic pulmonary fibrosis: Do alveolar epithelial cells and (myo)fibroblasts matter?
Xuefeng Xu et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2020)
Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts
Long Shuang Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Metastasis-associated protein 1 promotes epithelial-mesenchymal transition in idiopathic pulmonary fibrosis by up-regulating Snail expression
Weibin Qian et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
TGF-β Signaling
Kalliopi Tzavlaki et al.
BIOMOLECULES (2020)
Active mTOR in Lung Epithelium Promotes Epithelial-Mesenchymal Transition and Enhances Lung Fibrosis
Minako Saito et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Src family kinases and pulmonary fibrosis: A review
Hang Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Lipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways
Vidyani Suryadevara et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Latest progress on the molecular mechanisms of idiopathic pulmonary fibrosis
Yue Fang et al.
MOLECULAR BIOLOGY REPORTS (2020)
Fibrosis: from mechanisms to medicines
Neil C. Henderson et al.
NATURE (2020)
Comparison of reversal of rat pulmonary fibrosis of nintedanib, pirfenidone, and human umbilical mesenchymal stem cells from Wharton's jelly
Kuo-An Chu et al.
STEM CELL RESEARCH & THERAPY (2020)
Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis
Melissa Skibba et al.
FRONTIERS IN PHARMACOLOGY (2020)
CX3CL1 and CX3CR1 could be a relevant molecular axis in the pathophysiology of idiopathic pulmonary fibrosis
Selma Rivas-Fuentes et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling
Gali Epstein Shochet et al.
RESPIRATORY RESEARCH (2020)
Mitogen-activated Protein Kinase-activated Protein Kinase 2 Inhibition Attenuates Fibroblast Invasion and Severe Lung Fibrosis
Jiurong Liang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)
Developmental pathways in the pathogenesis of lung fibrosis
Diptiman Chanda et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Dysregulated Lung Commensal Bacteria Drive Interleukin-17B Production to Promote Pulmonary Fibrosis through Their Outer Membrane Vesicles
Daping Yang et al.
IMMUNITY (2019)
Chemokine (C-X-C motif) ligand 14 contributes to lipopolysaccharide-induced fibrogenesis in mouse L929 fibroblasts via modulating PPM1A
Li Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Aberrant expression of miR-125a-3p promotes fibroblast activation via Fyn/STAT3 pathway during silica-induced pulmonary fibrosis
Qi Xu et al.
TOXICOLOGY (2019)
Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis
Jarrod W. Barnes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2019)
Interleukin-18 promotes fibroblast senescence in pulmonary fibrosis through down-regulating Klotho expression
Li-Ming Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis and Right Heart Dysfunction A Prespecified Subgroup Analysis of a Double-Blind Randomized Clinical Trial (INSTAGE)
Juegen Y. Behr et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment
Steven D. Nathan et al.
RESPIRATORY MEDICINE (2019)
PTEN loss regulates alveolar epithelial cell senescence in pulmonary fibrosis depending on Akt activation
Ting Qiu et al.
AGING-US (2019)
Role of dual-specificity protein phosphatase DUSP10/MKP-5 in pulmonary fibrosis
Nikos Xylourgidis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2019)
IL-37 Attenuates Lung Fibrosis by Inducing Autophagy and Regulating TGF-β1 Production in Mice
Mi So Kim et al.
JOURNAL OF IMMUNOLOGY (2019)
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
Benjamin Ng et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Fibrocytes and fibroblasts-Where are we now
Sy Giin Chong et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease
Jie Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2019)
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis
Hannah V. Woodcock et al.
NATURE COMMUNICATIONS (2019)
IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity
Libang Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis
Milena S. Espindola et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Impact of Lung Function Decline on Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis (IPF)
M. Kreuter et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Single- Versus Double-Lung Transplantation in Pulmonary Fibrosis: Impact of Age and Pulmonary Hypertension
Mauricio A. Villavicencio et al.
ANNALS OF THORACIC SURGERY (2018)
FGF21 attenuates pulmonary fibrogenesis through ameliorating oxidative stress in vivo and in vitro
Shengqi Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations
Spyros A. Papiris et al.
CYTOKINE (2018)
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
Kevin R. Flaherty et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
Shaney L. Barratt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
Jessica Lawrence et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation
Hyun Young Koo et al.
JOURNAL OF PATHOLOGY (2018)
Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease
Joanne E. Murphy-Ullrich et al.
MATRIX BIOLOGY (2018)
Idiopathic Pulmonary Fibrosis
David J. Lederer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The hedgehog and Wnt/β-catenin system machinery mediate myofibroblast differentiation of LR-MSCs in pulmonary fibrogenesis
Xiang Chen et al.
CELL DEATH & DISEASE (2018)
Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis
Aina Martin-Medina et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
TGF-beta Signaling in Lung Health and Disease
Akira Saito et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Role of Fibroblast Growth Factor 10 in Mesenchymal Cell Differentiation During Lung Development and Disease
Jin Wu et al.
FRONTIERS IN GENETICS (2018)
Autotaxin in Pathophysiology and Pulmonary Fibrosis
Joanna Ninou et al.
FRONTIERS IN MEDICINE (2018)
PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses
Kazuya Tsubouchi et al.
INFLAMMATION AND REGENERATION (2018)
The JAK2 pathway is activated in idiopathic pulmonary fibrosis
Javier Milara et al.
RESPIRATORY RESEARCH (2018)
Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis Results of the INJOURNEY Trial
Carlo Vancheri et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
The Management of Patients With Idiopathic Pulmonary Fibrosis
Paolo Spagnolo et al.
FRONTIERS IN MEDICINE (2018)
Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets
Yi-Min Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis
Alan Betensley et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Toll-like receptors in the pathogenesis of pulmonary fibrosis
Theodoros Karampitsakos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
IL-13 and idiopathic pulmonary fibrosis: Possible links and new therapeutic strategies
Giovanni Passalacqua et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2017)
Potential benefit of bosentan therapy in borderline or less severe pulmonary hypertension secondary to idiopathic pulmonary fibrosis-an interim analysis of results from a prospective, single-center, randomized, parallel-group study
Yosuke Tanaka et al.
BMC PULMONARY MEDICINE (2017)
Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study
Kodai Kawamura et al.
BMC PULMONARY MEDICINE (2017)
Lower expression of platelet derived growth factor is associated with better overall survival rate of patients with idiopathic nonspecific interstitial pneumonia
Xuyou Zhu et al.
JOURNAL OF THORACIC DISEASE (2017)
Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activation
Ting Wang et al.
PLOS ONE (2017)
Differential Expression of VEGF-Axxx Isoforms Is Critical for Development of Pulmonary Fibrosis
Shaney L. Barratt et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis
Yong Huang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis
Philip L. Molyneaux et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro
Audrey Joannes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Radiologic-pathologic discordance in biopsy-proven usual interstitial pneumonia
Kunihiro Yagihashi et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis
Ganesh Raghu et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis
Chiko Shimbori et al.
JOURNAL OF PATHOLOGY (2016)
Mechanosensing by the α6-integrin confers an invasive fibroblast phenotype and mediates lung fibrosis
Huaping Chen et al.
NATURE COMMUNICATIONS (2016)
Nintedanib data challenge IPF guidelines
Patricia Lobo
LANCET RESPIRATORY MEDICINE (2016)
MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis
Stefen A. Boehme et al.
PLOS ONE (2016)
CXCR3 Requirement for the Interleukin-13-Mediated Up-Regulation of Interleukin-13Rα2 in Pulmonary Fibroblasts
Jennifer C. Barnes et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2015)
Nintedanib: A Review of Its Use in Patients with Idiopathic Pulmonary Fibrosis
Gillian M. Keating
DRUGS (2015)
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
Ganesh Raghu et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Molecular classification of idiopathic pulmonary fibrosis: Personalized medicine, genetics and biomarkers
Nathan Hambly et al.
RESPIROLOGY (2015)
Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis
Minoru Inomata et al.
CORE EVIDENCE (2015)
Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis
Tamera Corte et al.
RESPIRATORY RESEARCH (2015)
Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events
Ulrich Costabel et al.
ADVANCES IN THERAPY (2014)
Revealing the Pathogenic and Aging-related Mechanisms of the Enigmatic Idiopathic Pulmonary Fibrosis An Integral Model
Moises Selman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
Phillip L. Molyneaux et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Reviews and prospectives of signaling pathway analysis in idiopathic pulmonary fibrosis
Zheng Yan et al.
AUTOIMMUNITY REVIEWS (2014)
Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts
Enrico Conte et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis
David M. Habiel et al.
FRONTIERS IN PHARMACOLOGY (2014)
The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis
David N. O'Dwyer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Semaphorin 7a+ Regulatory T Cells Are Associated with Progressive Idiopathic Pulmonary Fibrosis and Are Implicated in Transforming Growth Factor-β1-induced Pulmonary Fibrosis
Ronald A. Reilkoff et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients
Edoardo Savarino et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model
Anne-Gaelle Besnard et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells
F. Guo et al.
LEUKEMIA (2013)
Increased Expression of Epidermal Growth Factor Receptor (EGF-R) in Patients with Different Forms of Lung Fibrosis
Argyris Tzouvelekis et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis A Randomized Trial
Maureen R. Horton et al.
ANNALS OF INTERNAL MEDICINE (2012)
IL1RN genetic variations and risk of IPF: a meta-analysis and mRNA expression study
Nicoline M. Korthagen et al.
IMMUNOGENETICS (2012)
Axin Pathway Activity Regulates in Vivo pY654-β-catenin Accumulation and Pulmonary Fibrosis
Arnau Ulsamer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Inhibition of α-SMA by the Ectodomain of FGFR2c Attenuates Lung Fibrosis
Wang Ju et al.
MOLECULAR MEDICINE (2012)
The Hedgehog Signal Transduction Network
David J. Robbins et al.
SCIENCE SIGNALING (2012)
Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis
Andreas Guenther et al.
EUROPEAN RESPIRATORY REVIEW (2012)
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Gastroesophageal Reflux Therapy Is Associated with Longer Survival in Patients with Idiopathic Pulmonary Fibrosis
Joyce S. Lee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
CCN2 Is Required for Bleomycin-Induced Skin Fibrosis in Mice
Shangxi Liu et al.
ARTHRITIS AND RHEUMATISM (2011)
Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44
Yuejuan Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition
Jason R. Rock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Antifibrotic activities of pirfenidone in animal models
C. J. Schaefer et al.
EUROPEAN RESPIRATORY REVIEW (2011)
Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease
Qingjian Wang et al.
FIBROGENESIS & TISSUE REPAIR (2011)
VEGF in the lung: a role for novel isoforms
Julia Varet et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
FGF-1 reverts epithelial-mesenchymal transition induced by TGF-β1 through MAPK/ERK kinase pathway
Carlos Ramos et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
Eotaxin-2/CCL24 and eotaxin-3/CCL26 exert differential profibrogenic effects on human lung fibroblasts
Martin Kohan et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Pirfenidone in idiopathic pulmonary fibrosis
H. Taniguchi et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent
Mark S. Wilson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway
S. Eliasz et al.
ONCOGENE (2010)
Resistance to Bleomycin-Induced Lung Fibrosis in MMP-8 Deficient Mice Is Mediated by Interleukin-10
Emilio Garcia-Prieto et al.
PLOS ONE (2010)
High concentrations of vascular endothelial growth factor reduce stretch-induced apoptosis of alveolar type II cells
Hartmut Kuhn et al.
RESPIROLOGY (2010)
Pulmonary fibrosis: pathogenesis, etiology and regulation
M. S. Wilson et al.
MUCOSAL IMMUNOLOGY (2009)
Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis
Yurika Yogo et al.
RESPIRATORY RESEARCH (2009)
An FGF-WNT gene regulatory network controls lung mesenchyme development
Yongjun Yin et al.
DEVELOPMENTAL BIOLOGY (2008)
Hyper-responsiveness of IPF/UIP fibroblasts: Interplay between TGF beta 1, IL-13 and CCL2
Lynne A. Murray et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Transforming growth factor β1 induces αvβ3 integrin expression in human lung fibroblasts via a β3 integrin-, c-Src-, and p38 MAPK-dependent pathway
Dmitri V. Pechkovsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Idiopathic pulmonary fibrosis
Eric B. Meltzer et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
The lysophosphatidic acid receptor LPA(1) links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
Andrew M. Tager et al.
NATURE MEDICINE (2008)
Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2
Jihane A. Faress et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration
Yuko Ishida et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Pathogenetic pathways and novel pharmaco therapeutic targets in idiopathic pulmonary fibrosis
Katerma M. Antomou et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2007)
Expression of chemokine receptors CXCR3 and CCR4 in lymphocytes of idiopathic nonspecific interstitial pneumonia
Takeo Yoshinouchi et al.
RESPIRATORY MEDICINE (2007)
Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling
Patricia C. Fulkerson et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-β in the lung
K. Nakagome et al.
THORAX (2006)
Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis
P Pignatti et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival
Marco Mura et al.
CRITICAL CARE (2006)
The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts
I Puxeddu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-β1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK
N Khalil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pathogenesis and natural history of usual interstitial pneumonia - The whole story or the last chapter of a long novel
RM Strieter
CHEST (2005)
Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts
M Hetzel et al.
LUNG (2005)
Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles
V Barbarin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis
Y Zhuo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal
MW Wynes et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung
CE Rose et al.
MICROCIRCULATION (2003)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs
YP Moodley et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Role of Raf in vascular protection from distinct apoptotic stimuli
A Alavi et al.
SCIENCE (2003)
Re-evaluation of fibrogenic cytokines in lung fibrosis
M Kelly et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Loss of HIF-2 and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice
V Compernolle et al.
NATURE MEDICINE (2002)
Protection from pulmonary fibrosis in the absence of CCR2 signaling
BB Moore et al.
JOURNAL OF IMMUNOLOGY (2001)
VEGF induces airway epithelial cell proliferation in human fetal lung in vitro
KRS Brown et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2001)
Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF
LH Pan et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Release of biologically active TGF-β from airway smooth muscle cells induces autocrine synthesis of collagen
A Coutts et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2001)
Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphisms
M Whyte et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo
T Arai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2000)
Share Paper
